UK trials show experimental Novavax coronavirus vaccine is 89.3% effective
Published
UK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus.
Full ArticlePublished
UK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus.
Full ArticleWatch VideoAnother drugmaker is sharing the data that their COVID vaccine works. In clinical trials of more than 43,000 people,..
Watch VideoAs far as these mutations… it happens all the time for viruses, but with COVID there are a few of these “variants of..